Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:2 Issue:7 Number:60 ISSN#:2564-2537
RCT
ACE Report #794
Ace Report Cover Metabolic Disorders

Parathyroid Hormone effective in fracture prevention in postmenopausal osteoporotic women


How to Cite

OrthoEvidence. Parathyroid Hormone effective in fracture prevention in postmenopausal osteoporotic women. ACE Report. 2013;2(7):60. Available from: https://myorthoevidence.com/AceReport/Report/794

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Randomized Trial

Ann Intern Med. 2007 Mar 6;146(5):326-39

Contributing Authors: SL Greenspan HG Bone MP Ettinger DA Hanley R Lindsay JR Zanchetta CM Blosch AL Mathisen SA Morris TB Marriott

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

2679 post menopausal women with osteoporosis were randomly assigned to receive either an injection of a parathyroid hormone (PTH), or a placebo, to examine the safety and efficacy of a PTH injection. The results at 18 months, indicated that PTH was successful in reducing the risk for first fracture in those who had no prevalent fracture, as well as reducing additional fracture risk in women who ha...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.